NCT04362072 2025-06-11Study of Lorlatinib In People With ALK-positive Non-small Cell Lung CancerPfizerPhase 4 Completed71 enrolled 26 charts
NCT01525550 2019-07-30A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine TumorsPfizerPhase 4 Completed106 enrolled 26 charts